FDA Approved: NOURIANZ — Original Application (Kyowa Kirin, Inc.)

View source ↗

Summary

FDA approved NOURIANZ (istradefylline) as an add-on therapy to levodopa/carbidopa for adults with Parkinson's disease to reduce off time.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Nourianz (istradefylline)

Snippet

ORIG AP for NOURIANZ (ISTRADEFYLLINE)